ClinicalTrials.Veeva

Menu

Screening Strategy for Early Diagnosis of Silicosis in At-Risk Populations in Oklahoma

University of Oklahoma (OU) logo

University of Oklahoma (OU)

Status

Completed

Conditions

Pneumoconiosis; Silica
Silicosis

Treatments

Diagnostic Test: Chest X-ray
Diagnostic Test: Tuberculosis test
Diagnostic Test: Pulmonary Function Test

Study type

Observational

Funder types

Other

Identifiers

NCT04205708
10140 (Registry Identifier)

Details and patient eligibility

About

Silicosis, a preventable yet irreversible occupational lung disease, has an insidious onset with a latency period for diagnosis extending beyond 10 years from the initial exposure. The central hypothesis of this study is that silicosis cases may currently be going undetected. The long-term goal of this research is to determine the current prevalence and forecast the future prevalence of silicosis and other pneumoconiosis among working populations in Oklahoma and to assist the public health and the healthcare system in planning for a potential resurgence of silicosis.

Enrollment

183 patients

Sex

All

Ages

30+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Male 30 years or older
  • Past or present employment in dusty environment, exposed to dust at work
  • Ability to consent and answer the questionnaire

Exclusion criteria

  • Female
  • Never exposed to dusty environment or never exposed to dust at work
  • Inability to consent and answer the questionnaire
  • Age 29 years or younger

Trial contacts and locations

1

Loading...

Central trial contact

Zain Asad, MD; Jad Kebbe, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems